Skip to main content
Top
Published in: Inflammation Research 7/2000

01-07-2000

Expression of hepatocyte growth factor and c-met in ulcerative colitis

Authors: Shinji Kitamura, Shinya Kondo, Yasuhisa Shinomura, Kouji Isozaki, Shuji Kanayama, Yoshifumi Higashimoto, Takeshi Minami, Tatsuya Kiyohara, Yuichi Yasunaga, Hideki Ishikawa, Toru Ohtani, Shingo Ishiguro, Yuji Matsuzawa

Published in: Inflammation Research | Issue 7/2000

Login to get access
Metadata
Title
Expression of hepatocyte growth factor and c-met in ulcerative colitis
Authors
Shinji Kitamura
Shinya Kondo
Yasuhisa Shinomura
Kouji Isozaki
Shuji Kanayama
Yoshifumi Higashimoto
Takeshi Minami
Tatsuya Kiyohara
Yuichi Yasunaga
Hideki Ishikawa
Toru Ohtani
Shingo Ishiguro
Yuji Matsuzawa
Publication date
01-07-2000
Publisher
Birkhäuser Verlag
Published in
Inflammation Research / Issue 7/2000
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/PL00000212

Other articles of this Issue 7/2000

Inflammation Research 7/2000 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine